Skanska sells Five to TRIUVA
Skanska has sold Five, a prestigious office building located in Prague, in the Czech Republic. The property has been acquired by a German real estate fund managed by TRIUVA Kapitalverwaltungsgesellschaft mbH, a Europeanwide active investment manager based in Frankfurt.
Five is a prestigious new office development whose green credentials are underpinned with LEED Platinum certification. The property providing 14,400 sq. m. GLA is already 100 percent leased MSD IT Global Innovation Center, part of Merck & Co Inc., a global healthcare leader and one of the largest pharmaceutical companies in the world occupies 80 percent of the building. The remaining space is leased to Roche Diagnostics, EBM Group, U1 and Sodexo. Five is located near Anděl – one of the busiest and most desirable office and retail destinations in Prague. With this purchase, TRIUVA has further diversified its commercial real estate portfolio.
“I am glad that TRIUVA has again invested in Skanska property and we can welcome them among our business partners in CEE. For the last years our region has become a well-regarded location with excellent risk-return spectrum. It is a region that gives a great opportunity for portfolio diversification. The Prague Office market is one of the top tiers here,” said Adrian Karczewicz, Head of Divestments at Skanska commercial development division for Central and Eastern Europe.
During the sales process, TRIUVA Kapitalverwaltungsgesellschaft mbH was advised by CBRE, and JLL acted as the exclusive agent for Skanska. Legal advisers for the transaction were Schonherr for the purchaser and Dentons for the seller.
Press release by Skanska.